CrossBridge Bio, Inc. — Form D

CrossBridge Bio, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-04. The offering totals $17.0M, of which $10.8M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-11-04
• Form: D
• Accession: 0002043521-24-000003
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $17.0M
• Amount sold: $10.8M
• Remaining: $6.2M
• Investors: 23
• Date of first sale: 2024-10-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-528610

Issuer

• Name: CrossBridge Bio, Inc.
• CIK: 0002043521
• Entity type: Corporation
• Jurisdiction: UNITED STATES
• Incorporated: 2023
• Address: 2450 HOLCOMBE BLVD, SUITE X, HOUSTON, TX, 77021
• Phone: (346) 547-5202

Officers, directors & promoters (10)

More

• CIK 2043521 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search